NO20044097L - Medications containing steroids and a new anticholinesterase drug - Google Patents

Medications containing steroids and a new anticholinesterase drug

Info

Publication number: NO20044097L
Authority: NO; Norway
Prior art keywords: new; medications containing; containing steroids; anticholinesterase drug; anticholinesterase
Prior art date: 2002-04-12

Application number

NO20044097A

Other languages

Norwegian (no)

Inventor

Georg Speck

Richard Reichl

Christopher John Montagu Meade

Helmut Meissner

Gerd Morschhauser

Michael P Pieper

Gerald Pohl

Rolf Banholzer

Michel Pairet

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-12

Filing date

2004-09-27

Publication date

2004-11-04

2004-09-27 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2004-11-04 Publication of NO20044097L publication Critical patent/NO20044097L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Dispersion Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20044097A 2002-04-12 2004-09-27 Medications containing steroids and a new anticholinesterase drug NO20044097L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10216429A DE10216429A1 (en)	2002-04-12	2002-04-12	Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide
PCT/EP2003/003668 WO2003086399A1 (en)	2002-04-12	2003-04-09	Medicaments containing steroids and a novel anticholinesterase drug

Publications (1)

Publication Number	Publication Date
NO20044097L true NO20044097L (en)	2004-11-04

Family

ID=28458802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044097A NO20044097L (en)	2002-04-12	2004-09-27	Medications containing steroids and a new anticholinesterase drug

Country Status (29)

Country	Link
EP (2)	EP1496902B1 (en)
JP (1)	JP4559086B2 (en)
KR (1)	KR101010869B1 (en)
CN (1)	CN1646126A (en)
AR (1)	AR039275A1 (en)
AT (1)	ATE312607T1 (en)
AU (1)	AU2003216921B2 (en)
BR (1)	BR0309085A (en)
CA (1)	CA2481268C (en)
DE (2)	DE10216429A1 (en)
DK (1)	DK1496902T3 (en)
EA (1)	EA008386B1 (en)
EC (1)	ECSP045355A (en)
ES (1)	ES2254917T3 (en)
HR (1)	HRP20040943B1 (en)
IL (2)	IL164391A0 (en)
ME (1)	MEP54208A (en)
MX (1)	MXPA04009917A (en)
MY (1)	MY137045A (en)
NO (1)	NO20044097L (en)
NZ (1)	NZ536284A (en)
PE (1)	PE20040326A1 (en)
PL (1)	PL211227B1 (en)
RS (1)	RS50776B (en)
TW (1)	TWI311055B (en)
UA (1)	UA80125C2 (en)
UY (1)	UY27758A1 (en)
WO (1)	WO2003086399A1 (en)
ZA (1)	ZA200406751B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0019172D0 (en)	2000-08-05	2000-09-27	Glaxo Group Ltd	Novel compounds
US6777399B2 (en)	2000-08-05	2004-08-17	Smithkline Beecham Corporation	Anti-inflammatory androstane derivative compositions
US6858596B2 (en)	2000-08-05	2005-02-22	Smithkline Beecham Corporation	Formulation containing anti-inflammatory androstane derivative
US7291608B2 (en)	2001-04-30	2007-11-06	Glaxo Group Limited	Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
RU2440813C2 (en)	2004-02-06	2012-01-27	Меда Фарма Гмбх Унд Ко.Кг	Combination (versions) and pharmaceutical preparation for treating upper respiratory tract diseases
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
SMT202000077T1 (en)	2009-05-29	2020-03-13	Pearl Therapeutics Inc	Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta-2 adrenergic receptor agonists and associated methods and systems
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
WO2014144894A1 (en)	2013-03-15	2014-09-18	Pearl Therapeutics, Inc.	Methods and systems for conditioning of particulate crystalline materials
CN115282411A (en) *	2022-01-14	2022-11-04	温州医科大学	A delivery system for delivering drugs into the brain using the nose and olfactory region and its application method

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
FR2585563B1 (en)	1985-07-30	1993-11-12	Glaxo Group Ltd	DEVICE FOR ADMINISTERING MEDICINES TO PATIENTS
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4108393A1 (en)	1991-03-15	1992-09-17	Boehringer Ingelheim Kg	NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
IL107120A (en)	1992-09-29	1997-09-30	Boehringer Ingelheim Int	Atomising nozzle and filter and spray generating device
DE4318455A1 (en)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Capsule holder
AU700837B2 (en) *	1995-04-28	1999-01-14	Banyu Pharmaceutical Co., Ltd.	1,4-di-substituted piperidine derivatives
DE19536903C2 (en)	1995-10-04	1998-09-10	Boehringer Ingelheim Int	Device for holding a fluidic component
DE19536902A1 (en)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Miniature fluid pressure generating device
DE19545226C1 (en)	1995-12-05	1997-06-19	Boehringer Ingelheim Int	Locking mechanism for a spring-operated output
GB0009591D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Medical combinations
DE10050994A1 (en) *	2000-10-14	2002-04-18	Boehringer Ingelheim Pharma	New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
WO2002036106A2 (en) *	2000-10-31	2002-05-10	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Novel medicament compositions based on anticholinergics and corticosteroids

2002
- 2002-04-12 DE DE10216429A patent/DE10216429A1/en not_active Withdrawn
2003
- 2003-04-09 CN CNA038083299A patent/CN1646126A/en active Pending
- 2003-04-09 BR BR0309085-0A patent/BR0309085A/en not_active IP Right Cessation
- 2003-04-09 PL PL371561A patent/PL211227B1/en not_active IP Right Cessation
- 2003-04-09 AR ARP030101241A patent/AR039275A1/en unknown
- 2003-04-09 CA CA2481268A patent/CA2481268C/en not_active Expired - Lifetime
- 2003-04-09 WO PCT/EP2003/003668 patent/WO2003086399A1/en not_active Ceased
- 2003-04-09 DE DE50301934T patent/DE50301934D1/en not_active Expired - Lifetime
- 2003-04-09 JP JP2003583418A patent/JP4559086B2/en not_active Expired - Lifetime
- 2003-04-09 IL IL16439103A patent/IL164391A0/en unknown
- 2003-04-09 ME MEP-542/08A patent/MEP54208A/en unknown
- 2003-04-09 AU AU2003216921A patent/AU2003216921B2/en not_active Expired
- 2003-04-09 NZ NZ536284A patent/NZ536284A/en not_active IP Right Cessation
- 2003-04-09 EA EA200401303A patent/EA008386B1/en not_active IP Right Cessation
- 2003-04-09 KR KR1020047016335A patent/KR101010869B1/en not_active Expired - Fee Related
- 2003-04-09 AT AT03712137T patent/ATE312607T1/en active
- 2003-04-09 HR HRP20040943AA patent/HRP20040943B1/en not_active IP Right Cessation
- 2003-04-09 ES ES03712137T patent/ES2254917T3/en not_active Expired - Lifetime
- 2003-04-09 EP EP03712137A patent/EP1496902B1/en not_active Expired - Lifetime
- 2003-04-09 DK DK03712137T patent/DK1496902T3/en active
- 2003-04-09 EP EP05109887A patent/EP1621197A3/en not_active Withdrawn
- 2003-04-09 RS YUP-899/04A patent/RS50776B/en unknown
- 2003-04-09 MX MXPA04009917A patent/MXPA04009917A/en active IP Right Grant
- 2003-04-10 UY UY27758A patent/UY27758A1/en not_active Application Discontinuation
- 2003-04-10 TW TW092108227A patent/TWI311055B/en not_active IP Right Cessation
- 2003-04-10 MY MYPI20031320A patent/MY137045A/en unknown
- 2003-04-10 PE PE2003000365A patent/PE20040326A1/en not_active Application Discontinuation
- 2003-09-04 UA UA20041109192A patent/UA80125C2/en unknown
2004
- 2004-08-25 ZA ZA200406751A patent/ZA200406751B/en unknown
- 2004-09-27 NO NO20044097A patent/NO20044097L/en not_active Application Discontinuation
- 2004-10-04 IL IL164391A patent/IL164391A/en not_active IP Right Cessation
- 2004-10-11 EC EC2004005355A patent/ECSP045355A/en unknown

Also Published As

Publication number	Publication date
CN1646126A (en)	2005-07-27
ES2254917T3 (en)	2006-06-16
UY27758A1 (en)	2003-11-28
RS89904A (en)	2006-10-27
EP1621197A3 (en)	2010-01-06
MEP54208A (en)	2011-05-10
BR0309085A (en)	2005-02-09
KR20050000391A (en)	2005-01-03
DE10216429A1 (en)	2003-10-23
WO2003086399A1 (en)	2003-10-23
AU2003216921B2 (en)	2008-03-13
ECSP045355A (en)	2005-01-28
HRP20040943A2 (en)	2005-04-30
MY137045A (en)	2008-12-31
EP1496902B1 (en)	2005-12-14
EA008386B1 (en)	2007-04-27
JP4559086B2 (en)	2010-10-06
RS50776B (en)	2010-08-31
CA2481268A1 (en)	2003-10-23
TWI311055B (en)	2009-06-21
IL164391A (en)	2010-11-30
ATE312607T1 (en)	2005-12-15
PL371561A1 (en)	2005-06-27
KR101010869B1 (en)	2011-01-26
ZA200406751B (en)	2006-12-27
EP1621197A2 (en)	2006-02-01
MXPA04009917A (en)	2004-12-07
NZ536284A (en)	2006-11-30
JP2005529105A (en)	2005-09-29
CA2481268C (en)	2011-07-12
AU2003216921A1 (en)	2003-10-27
DE50301934D1 (en)	2006-01-19
DK1496902T3 (en)	2006-05-08
HRP20040943B1 (en)	2013-05-31
PE20040326A1 (en)	2004-07-13
TW200403062A (en)	2004-03-01
UA80125C2 (en)	2007-08-27
PL211227B1 (en)	2012-04-30
AR039275A1 (en)	2005-02-16
EA200401303A1 (en)	2005-04-28
IL164391A0 (en)	2005-12-18
EP1496902A1 (en)	2005-01-19

Publication	Publication Date	Title
DK2266650T3 (en)	2014-12-15	A drug
DK1509266T3 (en)	2009-10-19	System comprising a nozzle and a holding system
NO20044097L (en)	2004-11-04	Medications containing steroids and a new anticholinesterase drug
AU154431S (en)	2004-02-04	Multi-panel computer display
IS7946A (en)	2005-07-19	drugs
NO20052860D0 (en)	2005-06-13	Pharmaceutical pellets comprising tamsulosin and a process for preparing the same
NO20043733L (en)	2004-10-20	Aryl-5-thio-Β-D-glucopyranoside derivatives and drugs for diabetes containing the same
NO20031776L (en)	2003-10-20	Zero-drilling completion and production system
EP1605895A4 (en)	2011-08-24	ORAL INSULIN THERAPY AND PROTOCOL
NO20032992L (en)	2003-12-29	System and procedure for implementing a counter
EP1387385A4 (en)	2008-10-29	PLASMA DISPLAY
DE60231189D1 (en)	2009-04-02	NG AND PLASMA DISPLAY DEVICE
NO20055173D0 (en)	2005-11-03	Pharmaceutical combination combination comprising modafinil and another drug
EP1381013A4 (en)	2009-05-06	PLASMA DISPLAY
ATE453390T1 (en)	2010-01-15	PHARMACEUTICAL COMPOSITION CONTAINING A LIPASE INHIBITOR AND GLUCOMANNAN
EP1750693A4 (en)	2010-06-02	OCULOSELECTIVE MEDICINES AND PROMEDICAMENTS
FR2870539B1 (en)	2006-08-04	NEW METHODS AND MEDICINES
NO20033709D0 (en)	2003-08-20	Medications including Diclofenac and Ornoprostil
EP1692125A4 (en)	2007-08-29	IRCINIASTATINES A AND B
ZA200406881B (en)	2006-06-28	Medicaments containing betamimetic drugs and a novel anticholineterase drug
NO20041649L (en)	2004-06-17	A combination product comprising melagatran and dexamethasone
EP1475090A4 (en)	2007-08-08	Drugs for mitochondrial diseases
SI1496902T1 (en)	2006-04-30	Drug, containing steroids and a new anticholinergic medicine
GB0209549D0 (en)	2002-06-05	Medication assembling device
GB2390437B (en)	2006-02-08	A display device

Legal Events

Date	Code	Title	Description
2013-12-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application